David Henry MD
Clinical Professor of Medicine, Pennsylvania Hospital, Philadelphia, PennsylvaniaIn addition to his clinical responsibilities, Dr. Henry is a member of the American Board of Internal Medicine’s Subspecialty SEP Board of Hematology and a principal investigator for the Eastern Cooperative Oncology Group, Accelerated Community Oncology Research Network, and International Oncology Network research groups. He is also principal investigator for several HIV oncology and cytokine studies with white blood cell and red blood cell growth factors. Dr. Henry’s main interests for publication and research are anemia and neutropenia in oncology. He is the Editor-in-Chief of MDEDGE.com/hematology-oncology and a reviewer for The New England Journal of Medicine, Journal of Clinical Oncology, Archives of Internal Medicine, and The Oncologist. He is also the author of a weekly podcast titled Blood and Cancer on iTunes.
Dr. Henry is a past winner of the annual Blockley-Osler Award for teaching at the University of Pennsylvania School of Medicine, and is the director of the University of Vienna medical student exchange program in Philadelphia. He also has appeared 3 times in Philadelphia magazine’s Top Doctors feature.
Positions:
Clinical Professor of Medicine, Pennsylvania Hospital, Philadelphia, PA
Member, Joan Karnell Cancer Center at Pennsylvania Hospital
Community oncologist
Degree:
University of Pennsylvania School of Medicine, MD
Postgraduate Training:
Resident, University of Pennsylvania School of Medicine
Fellow, University of Pennsylvania School of Medicine
Board Certification:
Medical oncology
Hematology
Clinical Interests:
Anemia, neutropenia, thrombocytopenia, and bone metastases
Recent Contributions to PracticeUpdate:
- Darbepoetin Alfa for Chemotherapy-Induced Anemia Among Patients With Advanced NSCLC
- Thromboembolism and Chemotherapy-Induced Anemia: New Data and Clinical Implications
- Impact of COVID-19 on Oncology Education
- Impact of COVID-19 on Clinical Oncology Practice
- COVID-19 and Coagulopathy
- ASCO 2020: Abstract Recommendations From Dr. David Henry for Lung Cancer
- AACR: Novel Checkpoint Inhibitor in Combination With Nivolumab for Advanced Solid Tumors
- ASCO 2020: Abstract Recommendations From Dr. David Henry
- 2019 Top Stories in Oncology: Liquid Biopsies
- ESMO 2019: Recommendations From Dr. David Henry